thrombotic thrombocytopenic purpuraMoschcowitzADAMTS 13plasmapheresiADAMTS 13тромботическая тромбоцитопеническая пурпураМошковицплазмафере1.Amorosi Е. L., Ultmann J. Е. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine (Baltimore) 1966; 45: 139-159.2.Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc. J. N. Y. Pathol. Soc. 1924; 24: 21-24. Reprinted in: Mt Sinai J. Med. 2003; 352-355.3.Moake J. L., Rudy С. K., Troll J. H. et al. Unusually large plasma factor VII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N. Engl. J. Med. 1982; 307: 1432-1435.4.Zheng X., Chung D., Takayama Т. K. et al. Structure of von Willebrand factor-cleaving protease (ADAMTS 13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J. Biol. Chem. 2001; 276: 41059-41063.5.Levy G. G., Nichols W. C., Lian E. C. et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-494.6.Furlan M., Robles R., Galbusera M. et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N. Engl. Med. 1998; 339: 1578-1584.7.Tsai H. M., Lian E. C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N. Engl. J. Med. 1998; 1585-1594.8.Furlan M., Lämmle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Best Pract. Res. Clin. Haematol. 2001; 14: 437-454.9.Bianchi V., Robles R., Alberio L. et al. Von Willebrand factor-cleaving protease (ADAMTS 13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 2002; 100: 710-713.10.Moake J. L. Thrombotic microangiopathies. N. Engl. J. Med. 2002; 347: 589-600.11.Bukowski R. M., King J. W., Hewlett J. S. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 1977; 50: 413-447.12.Barbot J., Costa E., Guerra M. et al. Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. Br. J. Haematol. 2001; 113: 649-651.13.Rock G. A., Shumak К. H., Buskard N. A. et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N. Engl. J. Med. 1991; 325: 393-397.14.Rock G., Shumak K., Kelton J. et al. Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Canadian Apheresis Study Group. Transfusion 1992; 32: 710-714.15.Воробьев А. И. Руководство по гематологии. M.: Ньюдиамед; 2005; т. 3: 108-110.16.Zheng X., Pallera A. M., Goodnough L. T. et al. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab. Ann. Intern. Med. 2002; 138: 105-108.